Cellectis Sa Stock Buy Hold or Sell Recommendation
| CLLS Stock | USD 1.87 0.01 0.54% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Cellectis SA is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Cellectis SA given historical horizon and risk tolerance towards Cellectis. When Macroaxis issues a 'buy' or 'sell' recommendation for Cellectis SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Cellectis Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Cellectis and provide practical buy, sell, or hold advice based on investors' constraints. Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Cellectis |
Execute Cellectis Buy or Sell Advice
The Cellectis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cellectis SA. Macroaxis does not own or have any residual interests in Cellectis SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cellectis' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Cellectis Trading Alerts and Improvement Suggestions
| Cellectis SA generated a negative expected return over the last 90 days | |
| Cellectis SA may become a speculative penny stock | |
| Cellectis SA has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 755 K. Net Loss for the year was (116.83 M) with profit before overhead, payroll, taxes, and interest of 23.95 M. | |
| Cellectis SA currently holds about 153.13 M in cash with (24.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cellectis SA has a frail financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Cellectiss SWOT analysis gene-editing firms stock faces pivotal year ahead |
Cellectis current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cellectis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cellectis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Cellectis Returns Distribution Density
The distribution of Cellectis' historical returns is an attempt to chart the uncertainty of Cellectis' future price movements. The chart of the probability distribution of Cellectis daily returns describes the distribution of returns around its average expected value. We use Cellectis SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cellectis returns is essential to provide solid investment advice for Cellectis.
| Mean Return | -0.28 | Value At Risk | -4.72 | Potential Upside | 4.05 | Standard Deviation | 2.94 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cellectis historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cellectis Stock Institutional Investors
The Cellectis' institutional investors refer to entities that pool money to purchase Cellectis' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | First Affirmative Financial Network | 2024-09-30 | 21.1 K | Bnp Paribas Arbitrage, Sa | 2024-06-30 | 16.7 K | Baird Financial Group, Inc. | 2024-09-30 | 15.1 K | Xtx Topco Ltd | 2024-09-30 | 13.1 K | Wells Fargo & Co | 2024-06-30 | 12.8 K | Geode Capital Management, Llc | 2024-09-30 | 10.8 K | Harbour Investments, Inc. | 2024-09-30 | 6.1 K | Rhumbline Advisers | 2024-06-30 | 3.9 K | Blackrock Inc | 2024-06-30 | 2.8 K | Long Focus Capital Management, Llc | 2024-09-30 | 4.6 M | Capital Research & Mgmt Co - Division 3 | 2024-09-30 | 1.8 M |
Cellectis Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (111.0M) | (99.4M) | (55.5M) | (92.4M) | 43.5M | 45.7M | |
| Free Cash Flow | (82.1M) | (126.5M) | (124.3M) | (89.9M) | (25.8M) | (27.1M) | |
| Depreciation | 6.9M | 9.8M | 16.6M | 18.4M | 18.5M | 19.4M | |
| Other Non Cash Items | (8.3M) | 12.0M | (5.6M) | (7.6M) | 71.9M | 75.5M | |
| Capital Expenditures | 13.0M | 46.3M | 19.7M | 2.4M | 1.1M | 1.0M | |
| Net Income | (115.2M) | (97.5M) | (125.1M) | (98.7M) | (116.8M) | (111.0M) | |
| End Period Cash Flow | 340.5M | 241.1M | 185.6M | 93.2M | 136.7M | 175.2M | |
| Change To Inventory | (37K) | (2.6M) | 1.3M | 1.6M | 1.7M | 0.0 | |
| Investments | (35.9M) | (54.3M) | 27.0M | (2.8M) | (15.5M) | (14.7M) | |
| Net Borrowings | (3.4M) | 17.6M | (12.5M) | (6.6M) | (5.9M) | (5.6M) | |
| Change To Netincome | 14.4M | 12.8M | (2.8M) | 6.0M | 5.4M | 5.1M |
Cellectis Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cellectis or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cellectis' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cellectis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.37 | |
β | Beta against Dow Jones | 0.61 | |
σ | Overall volatility | 2.96 | |
Ir | Information ratio | -0.14 |
Cellectis Volatility Alert
Cellectis SA exhibits very low volatility with skewness of 0.67 and kurtosis of 1.33. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cellectis' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cellectis' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cellectis Fundamentals Vs Peers
Comparing Cellectis' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cellectis' direct or indirect competition across all of the common fundamentals between Cellectis and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cellectis or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cellectis' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cellectis by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cellectis to competition |
| Fundamentals | Cellectis | Peer Average |
| Return On Equity | -0.82 | -0.31 |
| Return On Asset | -0.16 | -0.14 |
| Profit Margin | (2.34) % | (1.27) % |
| Operating Margin | (0.60) % | (5.51) % |
| Current Valuation | 11.48 M | 16.62 B |
| Shares Outstanding | 100.09 M | 571.82 M |
| Shares Owned By Insiders | 3.86 % | 10.09 % |
| Shares Owned By Institutions | 14.60 % | 39.21 % |
| Number Of Shares Shorted | 156.19 K | 4.71 M |
| Price To Earning | (14.84) X | 28.72 X |
| Price To Book | 1.45 X | 9.51 X |
| Price To Sales | 5.19 X | 11.42 X |
| Revenue | 755 K | 9.43 B |
| Gross Profit | 23.95 M | 27.38 B |
| EBITDA | (98.09 M) | 3.9 B |
| Net Income | (116.83 M) | 570.98 M |
| Cash And Equivalents | 153.13 M | 2.7 B |
| Cash Per Share | 3.37 X | 5.01 X |
| Total Debt | 92.85 M | 5.32 B |
| Debt To Equity | 0.52 % | 48.70 % |
| Current Ratio | 3.17 X | 2.16 X |
| Book Value Per Share | 1.29 X | 1.93 K |
| Cash Flow From Operations | (24.75 M) | 971.22 M |
| Short Ratio | 3.28 X | 4.00 X |
| Earnings Per Share | (1.16) X | 3.12 X |
| Target Price | 6.5 | |
| Number Of Employees | 216 | 18.84 K |
| Beta | 3.2 | -0.15 |
| Market Capitalization | 187.18 M | 19.03 B |
| Total Asset | 334.27 M | 29.47 B |
| Retained Earnings | (405.76 M) | 9.33 B |
| Working Capital | 77.86 M | 1.48 B |
| Current Asset | 51 M | 9.34 B |
Cellectis Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cellectis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cellectis Buy or Sell Advice
When is the right time to buy or sell Cellectis SA? Buying financial instruments such as Cellectis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cellectis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Office Supplies Thematic Idea Now
Office Supplies
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.